Skip to main navigation

Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Events and Presentations

Events and Presentations

Presentations

October 21, 2021

Athira Corporate Presentation October 2021 2.4 MB

July 26, 2021

Quantitative EEG as a translational measure for the assessment of ATH-1017 neurophysiological changes in mild-to-moderate Alzheimer’s disease. (Alzheimer’s Association International Conference 2021 (AAIC), Poster #56531) 807.2 KB

Upcoming Events

Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

November 10, 2021 at 11:50 AM EST

Link to CTAD 2021 Conference

Past Events

Athira Corporate Update

October 21, 2021 at 4:30 PM EDT

Athira Pharma Virtual KOL Webinar – Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway

April 15, 2021 at 4:30 PM EDT

Access the Webinar

Supporting Materials

View Presentation 2 MB

Athira Pharma Virtual KOL Webinar – The Predictive Nature of P300 to Determine Clinical Benefit of Alzheimer’s Disease Treatments

October 28, 2020 at 4:00 PM EDT

Access the Webinar

Supporting Materials

View Presentation 3.4 MB

View Video Directory 164.9 KB

Athira Closing Bell Ceremony

September 29, 2020

View Closing Bell Ceremony

Print Page

Email Alerts

Contact IR

Contact

Athira Pharma
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

> Footer Social

Tweets by athirapharma

© 2021 Athira Pharma. All Rights Reserved.